Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: Elllk who wrote (3793)	7/30/1998 12:56:00 AM
From: Jonathan Schonsheck	Read Replies (5) \| Respond to of 4342

CONTESTCONTESTCONTESTCONTEST Dear Threaders - I was thinking about the design of a contest called "Bustin' a Buck," wherein contestants - you - would predict the event that would propel PRLN past the $1.00 point. But that, as the saying goes, is history. So: I hereby announce a contest: "Doin' a Deuce." The contestants - you - are to predict what event will send the stock past the $2.00 mark. Everyone can participate in designing the contest & suggesting rules. I propose: predictions must be quite specific, and not vague ("the announcement of good news"). The decision of the Market is final. What, besides our admiration, can we offer to the winner? Should the predictions have to include a date? Here are some possible entries; the floor is open for additions to the list. Paracelsian announces the first major clients for BioFIT Certification Scherer announces the first major clients for BioFIT Certification Paracelsian announces promising results from the collaboration with Southern Research Institute SRI announces promising results from the collaboration with Paracelsian Paracelsian announces the world-wide agreement with Scherer Scherer announces the world-wide agreement with Paracelsian Paracelsian files SEC 8-K with financial details of world-wide agreement with Scherer Paracelsian files SEC 10-Q showing profitability The U.S. Patent Office grants "Petition to Make Special" as regards the use of Andrographalyde "for treating cancer, HIV, angiogenesis, Alzheimer's and hepatitis, and depression" The U.S. Patent Office grants a patent for the first of the BioFIT assays Paracelsian announces a partnership/plan to market Andrographalyde Paracelsian announces a major sale of its Ah-Immunoassay for dioxins A major brokerage house announces that it is initiating coverage of PRLN Some source of capital makes a private investment in Paracelsian (a la Travelers) A large-circulation stock letter cites Leo Rishty's "Unique Situations" (a la Dick Davis Digest, April 1996) While a guest on CNBC, Jack Rivkin of Travelers comments on Paracelsian's arising, phoenix-like, from the ashes.